Giá của PaxMedica, Inc. Common Stock là bao nhiêu (PXMD)

Giá của PaxMedica, Inc. Common Stock (PXMD) là $0.0005

Mũ thị trường của PaxMedica, Inc. Common Stock là gì (PXMD)

Giới hạn thị trường của PaxMedica, Inc. Common Stock (PXMD) là $63.13K

Lịch sử giá PaxMedica, Inc. Common Stock (PXMD)

PaxMedica, Inc. is a biopharmaceutical company currently in the clinical development phase, dedicated to advancing anti-purinergic drug therapies (APTs). These innovative treatments are specifically designed to address complex neurological disorders presenting with stubborn and persistent symptoms. The company's primary investigative drug is PAX-101, an intravenous (IV) form of suramin, which is being explored for a variety of conditions. These include autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, post-COVID-19 syndrome (commonly known as "long COVID"), and human African trypanosomiasis. Furthermore, PaxMedica is also developing PAX-102, an intranasal version of suramin, intended for various neurological applications. The company, which was incorporated in 2018 and has its headquarters in Tarrytown, New York, previously operated as Purinix Pharmaceuticals LLC before rebranding to PaxMedica, Inc. in April 2020. It functions as a subsidiary of Tardimed Sciences LLC.

Năm	Hiệu suất
2026 (TTM)	0.00%
2025	-99.67%
2024	-90.14%
2023	-97.74%
2022	0.00%

Năm

Hiệu suất

2026 (TTM)

0.00%

2025

-99.67%

2024

-90.14%

2023

-97.74%

2022

0.00%

Công ty	Giá cổ phiếu	Thay đổi 1năm%	Quốc gia
Vertex Pharmaceuticals Incorporated VRTX.US	$523.97	32.34%	US
Argenx SE ARGX.US	$867.22	34.12%	NL
Lonza Group AG LONN.SW	$744.96	8.94%	CH
Samsung Biologics Co.,Ltd. 207940.KS	$1.08K	-6.68%	KR
UCB S.A. UCB.BR	$259.89	16.65%	BE

Công ty

Giá cổ phiếu

Thay đổi 1năm%

Quốc gia